AI assistant
JOHNSON & JOHNSON — Director's Dealing 2004
Apr 28, 2004
29750_dirs_2004-04-28_ebe8bc9d-3fb7-4894-958c-16ee66f19408.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BARRIER THERAPEUTICS INC (BTRX)
CIK: 0001173657
Period of Report: 2004-04-28
Reporting Person: JOHNSON & JOHNSON (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Convertible Preferred Stock | $ | Common Stock (2033333) | Indirect | ||
| Series A Convertible Preferred Stock | $ | Common Stock (6300000) | Indirect | ||
| Series B Convertible Preferred Stock | $ | Common Stock (50000) | Indirect | ||
| Series C Convertible Preferred Stock | $ | Common Stock (512820) | Indirect |
Footnotes
F1: All of the outstanding shares of the Issuer's Series A Convertible Preferred Stock will convert automatically on a 2 for 1 basis into Common Stock of the Company prior to the Issuer's initial public offering.
F2: The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by this subsidiary of the Reporting Person.
F3: All of the outstanding shares of the Issuer's Series B Convertible Preferred Stock will convert automatically on a 2 for 1 basis into Common Stock of the Company prior to the Issuer's initial public offering.
F4: All of the outstanding shares of the Issuer's Series C Convertible Preferred Stock will convert automatically on a 2 for 1 basis into Common Stock of the Company prior to the Issuer's initial public offering.